EV/EBITDA
93.01
-1.77-1.87%
10 min ago
Summary
- As of February 24, 2025, AKBA EV/EBITDA is 93.01, with a fall of -1.77 (-1.87%) during the most recent trading day.
- Over the past year, AKBA EV/EBITDA has increased by +127.07 (+373.08%).
- AKBA EV/EBITDA is now -63.77% below its all-time high of 256.75.
Performance
AKBA EV/EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
EV/EBITDA Formula
EV/EBITDA = Enterprise Value
TTM EBITDA
Enterprise Value
TTM EBITDA
TTM EBITDA
AKBA EV/EBITDA Trends
PeriodPeriod | EV/EBITDAEV/EBITDA | Enterprise valueEnterprise value | PricePrice |
---|---|---|---|
todaytoday | -1.9% | -1.9% | -1.9% |
1 m1 month | -25.7% | -25.7% | -26.5% |
3 m3 months | -5.9% | -5.9% | -6.1% |
6 m6 months | +29.8% | +20.5% | +15.3% |
ytdytd | -6.9% | -6.9% | -7.2% |
1 y1 year | +373.1% | +42.0% | +24.3% |
5 y5 years | +2058.1% | -66.0% | -82.3% |
AKBA EV/EBITDA Highs & Lows
PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
---|---|---|---|---|---|
1 m | 1-month | -25.7% | 93.01 | at low | |
3 m | 3-month | 125.25 | -25.7% | 93.01 | at low |
6 m | 6-month | 125.25 | -25.7% | 61.23 | +51.9% |
1 y | 1-year | 256.75 | -63.8% | -55.60 | +267.3% |
3 y | 3-year | 256.75 | -63.8% | -55.60 | +267.3% |
5 y | 5-year | 256.75 | -63.8% | -55.60 | +267.3% |
alltime | all time | 256.75 | -63.8% | -55.60 | +267.3% |
Akebia Therapeutics EV/EBITDA History
Date | Value |
---|---|
2025 | 93.01(-6.9%) |
2024 | 99.91(-435.0%) |
2023 | -29.82(+935.4%) |
2022 | -2.88(+68.4%) |
2021 | -1.71(+87.9%) |
2020 | -0.91(-69.2%) |
Date | Value |
---|---|
2019 | -2.95(-6.9%) |
2018 | -3.17(-62.2%) |
2017 | -8.39(+431.0%) |
2016 | -1.58(-72.0%) |
2015 | -5.64(+4.6%) |
2014 | -5.39 |
FAQ
- What is Akebia Therapeutics EV/EBITDA?
- What is the all time high EV/EBITDA for Akebia Therapeutics?
- What is AKBA EV/EBITDA year-to-date change?
- What is Akebia Therapeutics EV/EBITDA year-on-year change?
What is Akebia Therapeutics EV/EBITDA?
The current EV/EBITDA of AKBA is 93.01
What is the all time high EV/EBITDA for Akebia Therapeutics?
Akebia Therapeutics all-time high EV/EBITDA is 256.75
What is AKBA EV/EBITDA year-to-date change?
Akebia Therapeutics EV/EBITDA has changed by -6.90 (-6.91%) since the beginning of the year
What is Akebia Therapeutics EV/EBITDA year-on-year change?
Over the past year, AKBA EV/EBITDA has changed by +127.07 (+373.08%)